Why the IPO market is booming and busting
Flotations have stalled and returns from new listings have been weak
We haven't written up this one. Financial Times has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
Flotations have stalled and returns from new listings have been weak
We haven't written up this one. Financial Times has the full story — the link below goes straight to it.
The RBI is expected to raise the repo rate by 25 basis points in its October policy review as inflation pressures build from higher crude prices, the West Asia conflict and global monetary tightening…
Keeping costs as low as possible is key to investing. Overpaying by even a fraction of a percentage point can erode the value of your nest egg by thousands over time.
Key PointsEli Lilly dominates the weight loss drug market, one that’s on track to approach $100 billion in just a few years.
The media company paid through the nose for its record-setting bond deal. Other corporate issuers will too.
There are blazing deals for some of the top healthcare stocks -- companies with proven track records and dividend yields as high as 6%.
Investors should get comfortable owning what has become a capital-intensive business.